Who owns ANEBULO PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Anebulo Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Anebulo Pharmaceuticals stock

Who bought or sold ANEBULO PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
22NW 5.4M $13M 6% Dec 2023
 View chart
LVW Advisors 643k $1.6M -4% Dec 2023
 View chart
Nantahala Capital Management 511k $1.2M 0% Dec 2023
 View chart
Mangrove Partners 399k $1.2M 0% Sep 2023
 View chart
Ikarian Capital 158k $382k 0% Dec 2023
 View chart
Vanguard Group 153k $370k 585% Dec 2023
 View chart
Tower Research Capital 21k $64k 242% Sep 2023
 View chart
Boothbay Fund Management 19k $58k 10% Sep 2023
 View chart
Landscape Capital Management 15k $36k 100% Dec 2023
 View chart
BlackRock 4.2k $13k -42% Sep 2023
 View chart
ADAR1 Capital Management 1.2k $2.9k 100% Dec 2023
 View chart
Royal Bank of Canada 71.00 $0 48% Dec 2023
 View chart
Wells Fargo & Company 61.00 $147.998200 5% Dec 2023
 View chart
Bank of America Corporation 4.00 $10.000000 100% Dec 2023
 View chart

Who sold out of Anebulo Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Praetorian PR Sep 2023 177k $542k